Published in BJOG on November 30, 2012
Familial hypercholesterolemia: developments in diagnosis and treatment. Dtsch Arztebl Int (2014) 2.12
Statins and congenital malformations: cohort study. BMJ (2015) 1.75
Statins in pregnancy: safety and perspectives of therapeutic applications. BJOG (2013) 1.08
Effect of pravastatin on total kidney volume, left ventricular mass index, and microalbuminuria in pediatric autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol (2014) 1.05
Safety and pharmacokinetics of pravastatin used for the prevention of preeclampsia in high-risk pregnant women: a pilot randomized controlled trial. Am J Obstet Gynecol (2015) 0.88
Maternal pravastatin prevents altered fetal brain development in a preeclamptic CD-1 mouse model. PLoS One (2014) 0.83
Statins inhibit insulin-like growth factor action in first trimester placenta by altering insulin-like growth factor 1 receptor glycosylation. Mol Hum Reprod (2014) 0.77
Should We Add Pravastatin to Aspirin for Preeclampsia Prevention in High-risk Women? Clin Obstet Gynecol (2016) 0.75
Use of medication for cardiovascular disease during pregnancy. Nat Rev Cardiol (2015) 0.75
Authors' response to: Statins in pregnancy: safety and perspectives of therapeutic applications. BJOG (2013) 0.75
The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med (1997) 13.96
Tumour necrosis factor alpha in stool as a marker of intestinal inflammation. Lancet (1992) 6.66
Efavirenz plasma levels can predict treatment failure and central nervous system side effects in HIV-1-infected patients. AIDS (2001) 5.52
The lux autoinducer regulates the production of exoenzyme virulence determinants in Erwinia carotovora and Pseudomonas aeruginosa. EMBO J (1993) 5.35
A novel procedure for quantitative polymerase chain reaction by coamplification of competitive templates. Gene (1992) 3.48
Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis. The CB0006 Sepsis Syndrome Study Group. Crit Care Med (1993) 2.84
Genetic control of the CD4/CD8 T-cell ratio in humans. Nat Med (1995) 2.75
Hepatitis after germander (Teucrium chamaedrys) administration: another instance of herbal medicine hepatotoxicity. Ann Intern Med (1992) 2.47
Anti-TNF therapy inhibits fever in cerebral malaria. Q J Med (1993) 2.47
Analysis of HIV-1 load in blood, semen and saliva: evidence for different viral compartments in a cross-sectional and longitudinal study. AIDS (1996) 2.41
Microarray application in prenatal diagnosis: a position statement from the cytogenetics working group of the Italian Society of Human Genetics (SIGU), November 2011. Ultrasound Obstet Gynecol (2012) 2.38
Resistance to antidepressant medications and short-term clinical response to ECT. Am J Psychiatry (1996) 2.32
Significance of systemic endotoxaemia in inflammatory bowel disease. Gut (1995) 2.21
High vitamin A intake in early pregnancy and major malformations: a multicenter prospective controlled study. Teratology (1999) 2.12
Evaluation of prenatal ultrasound diagnosis of fetal abdominal wall defects by 19 European registries. Ultrasound Obstet Gynecol (2001) 2.10
Therapeutic antibody fragments with prolonged in vivo half-lives. Nat Biotechnol (1999) 2.02
Prevalence and determinants of QT interval prolongation in medical inpatients. Intern Med J (2012) 2.01
Philtrum length and intercommissural distance in newborn infants. J Med Genet (1983) 1.96
Cytokines in stools of children with inflammatory bowel disease or infective diarrhoea. J Clin Pathol (1993) 1.96
Sexual transmission of the hepatitis C virus and efficacy of prophylaxis with intramuscular immune serum globulin. A randomized controlled trial. Arch Intern Med (1997) 1.92
Excimer laser ablation of the human lens at 308 nm with a fiber delivery system. J Cataract Refract Surg (1989) 1.92
The spectrum of congenital anomalies of the VATER association: an international study. Am J Med Genet (1997) 1.91
Resistance reversal by RNAi silencing of MDR1 in CML cells associated with increase in imatinib intracellular levels. Leukemia (2007) 1.89
Absolute quantitation of viremia in human immunodeficiency virus infection by competitive reverse transcription and polymerase chain reaction. J Clin Microbiol (1992) 1.85
A phase II study of vinflunine in bladder cancer patients progressing after first-line platinum-containing regimen. Br J Cancer (2006) 1.85
Molecular profile of human immunodeficiency virus type 1 infection in symptomless patients and in patients with AIDS. J Virol (1992) 1.80
Prospective study of new-onset seizures presenting as status epilepticus in childhood. Neurology (2010) 1.69
Natural history of inoperable hepatocellular carcinoma: estrogen receptors' status in the tumor is the strongest prognostic factor for survival. Hepatology (2000) 1.64
Monitoring methylmercury during pregnancy: maternal hair predicts fetal brain exposure. Neurotoxicology (1995) 1.64
Risk factors of sensorineural hearing loss in preterm infants. Biol Neonate (1997) 1.63
Evaluation of LRRK2 G2019S penetrance: relevance for genetic counseling in Parkinson disease. Neurology (2007) 1.61
Recombination hotspot in NF1 microdeletion patients. Hum Mol Genet (2001) 1.61
Gestational diabetes mellitus. A survey of perinatal complications in the 1980s. Diabetes (1991) 1.61
Longitudinal neurodevelopmental study of Seychellois children following in utero exposure to methylmercury from maternal fish ingestion: outcomes at 19 and 29 months. Neurotoxicology (1995) 1.60
Marked parental consanguinity as a cause for increased major malformations in an Israeli Arab community. Am J Med Genet (1992) 1.59
Barriers to influenza immunization in a low-income urban population. Am J Prev Med (2001) 1.59
Pharmacogenetics-based population pharmacokinetic analysis of efavirenz in HIV-1-infected individuals. Clin Pharmacol Ther (2009) 1.57
Lung and blood T-cell receptor repertoire in extrinsic allergic alveolitis. Eur Respir J (1997) 1.54
Monoclonal antibody to TNF in severe septic shock. Lancet (1990) 1.53
Assessing prognosis and optimizing treatment in patients with postchemotherapy viable nonseminomatous germ-cell tumors (NSGCT): results of the sCR2 international study. Ann Oncol (2007) 1.52
Hospitalization for early bonding of the genetic mother after a surrogate pregnancy: report of two cases. Birth (2001) 1.52
Searching for psoriasis susceptibility genes in Italy: genome scan and evidence for a new locus on chromosome 1. J Invest Dermatol (1999) 1.50
Influenza A/H1N1v in pregnancy: an investigation of the characteristics and management of affected women and the relationship to pregnancy outcomes for mother and infant. Health Technol Assess (2010) 1.49
Identification of a SUFU germline mutation in a family with Gorlin syndrome. Am J Med Genet A (2009) 1.49
NINDS AIREN neuroimaging criteria do not distinguish stroke patients with and without dementia. Neurology (2004) 1.48
Population pharmacokinetics of imatinib and the role of alpha-acid glycoprotein. Br J Clin Pharmacol (2006) 1.46
Psychopharmacology in supportive care of cancer: a review for the clinician. III. Antidepressants. Support Care Cancer (2000) 1.45
Prenatal detection of congenital renal malformations by fetal ultrasonographic examination: an analysis of 709,030 births in 12 European countries. Eur J Med Genet (2005) 1.45
Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer. Ann Oncol (2012) 1.44
How wide is the clinical spectrum of the acrocallosal syndrome? Report of a mild case. J Med Genet (1990) 1.44
Adams-Oliver syndrome: autosomal recessive inheritance and new phenotypic-anthropometric findings. Am J Med Genet (1998) 1.43
Suction purpura. Arch Dermatol (1992) 1.41
Medication use in pregnancy: a cross-sectional, multinational web-based study. BMJ Open (2014) 1.41
Ranitidine-induced bradycardia in a neonate--a first report. Eur J Pediatr (1993) 1.41
Hemophilia and nonprogressing human immunodeficiency virus type 1 infection. Blood (1997) 1.41
The effect of light on oxygen-induced vasoproliferative retinopathy in newborn kittens. Invest Ophthalmol Vis Sci (1992) 1.41
Mental health parity: clarifying our objectives. Psychiatr Serv (1997) 1.40
Fetal hyperechogenic kidney with normal amniotic fluid volume: a diagnostic dilemma. Prenat Diagn (2005) 1.39
Defective intracellular transport and processing of OA1 is a major cause of ocular albinism type 1. Hum Mol Genet (2000) 1.38
Phagocyte function and cytokine production in community acquired pneumonia. Thorax (1994) 1.35
Evidence for different effects of soluble TNF-receptors on various TNF measurements in human biological fluids. Lancet (1991) 1.35
Genetic analysis in Italian families with inflammatory bowel disease supports linkage to the IBD1 locus--a GISC study. Eur J Hum Genet (1999) 1.32
Scalp changes after fetal monitoring. Arch Dis Child (1985) 1.32
Homozygous delta 32 deletion of the CCR-5 chemokine receptor gene in an HIV-1-infected patient. AIDS (1997) 1.32
Hepatitis associated with amoxycillin-clavulanic acid combination report of 15 cases. Gut (1992) 1.28
Wasting, ischemia, and lymphoid abnormalities in mice expressing T cell-targeted human tumor necrosis factor transgenes. J Immunol (1993) 1.27
Disappearance rate of catecholamines, total metanephrines, and neuropeptide Y from the plasma of patients after resection of pheochromocytoma. Clin Chem (2001) 1.27
Dynamics and modulation of human immunodeficiency virus type 1 transcripts in vitro and in vivo. J Virol (1996) 1.27
Detection of human immunodeficiency virus type 1 genomic RNA in plasma samples by reverse-transcription polymerase chain reaction. J Med Virol (1991) 1.26
Bacteriostasis of Escherichia coli by milk. II. Effect of bicarbonate and transferrin on the activity of infant feeds. J Hyg (Lond) (1977) 1.25
Mental retardation and cardiovascular malformations in NF1 microdeleted patients point to candidate genes in 17q11.2. J Med Genet (2004) 1.25
Evaluation of prenatal diagnosis of congenital heart diseases by ultrasound: experience from 20 European registries. Ultrasound Obstet Gynecol (2001) 1.25
The EGF-CFC family: novel epidermal growth factor-related proteins in development and cancer. Endocr Relat Cancer (2000) 1.22
Teratogenic effects of antiepileptic drugs: use of an International Database on Malformations and Drug Exposure (MADRE). Epilepsia (2000) 1.21
Dissection of human humoral immune response against hepatitis C virus E2 glycoprotein by repertoire cloning and generation of recombinant Fab fragments. Hepatology (1998) 1.21
Racial differences in survival from gynecologic cancer. Obstet Gynecol (1996) 1.20
Intracellular measurements of anti-HIV drugs indinavir, amprenavir, saquinavir, ritonavir, nelfinavir, lopinavir, atazanavir, efavirenz and nevirapine in peripheral blood mononuclear cells by liquid chromatography coupled to tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci (2005) 1.20
Uptake and retention of mercury in the mouse brain. A comparison of exposure to mercury vapor and intravenous injection of mercuric salt. Arch Environ Health (1966) 1.20
Mapping B-cell epitopes of hepatitis C virus E2 glycoprotein using human monoclonal antibodies from phage display libraries. J Virol (2001) 1.19
Rate, type, and cost of adverse drug reactions in emergency department admissions. Eur J Intern Med (2001) 1.19
Spectrum of clinical variability in familial deletion 22q11.2: from full manifestation to extremely mild clinical anomalies. Clin Genet (2003) 1.18
Evaluation of the prenatal diagnosis of limb reduction deficiencies. EUROSCAN Study Group. Prenat Diagn (2000) 1.17
Assessment of ear length and low set ears in newborn infants. J Med Genet (1983) 1.17
Adverse effects of prenatal methimazole exposure. Teratology (2001) 1.17
Pertussis antibodies in the sera of children exposed to Bordetella pertussis by vaccination or infection. J Hyg (Lond) (1973) 1.16
The metabolism of glyceryl trinitrate to nitric oxide in the macrophage cell line J774 and its induction by Escherichia coli lipopolysaccharide. Biochem Pharmacol (1992) 1.16
Quantitative molecular monitoring of human immunodeficiency virus type 1 activity during therapy with specific antiretroviral compounds. J Clin Microbiol (1995) 1.16
Metabolism of glyceryl trinitrate to nitric oxide by endothelial cells and smooth muscle cells and its induction by Escherichia coli lipopolysaccharide. Proc Natl Acad Sci U S A (1992) 1.16
Differentiating benign from malignant lung lesions using "quantitative" parameters of FDG PET images. Clin Nucl Med (1996) 1.16
Breath concentration as an index of the health risk from benzene. Studies on the accumulation and clearance of inhaled benzene. Scand J Work Environ Health (1980) 1.15
Congenital depression of the neonatal skull. Eur J Obstet Gynecol Reprod Biol (1986) 1.15
Molecular characterization and dynamics of hepatitis C virus replication in human fetal hepatocytes infected in vitro. Hepatology (1997) 1.15
Rat mast cells synthesize a nitric oxide like-factor which modulates the release of histamine. Agents Actions (1991) 1.14
Maximising the duration of disease control in metastatic renal cell carcinoma with targeted agents: an expert agreement. Med Oncol (2011) 1.14
Proteomic study of salivary peptides and proteins in patients with Sjögren's syndrome before and after pilocarpine treatment. Arthritis Rheum (2007) 1.14
Evolution of hypervariable region 1 of hepatitis C virus in primary infection. J Virol (1998) 1.13
Molecular studies in 20 submicroscopic neurofibromatosis type 1 gene deletions. Hum Mutat (1999) 1.13